MannKind Corp
MNKD
#4917
Rank
NZ$3.01 B
Marketcap
NZ$9.83
Share price
-0.53%
Change (1 day)
-14.06%
Change (1 year)

MannKind Corp (MNKD) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.20 Billion

According to MannKind Corp's latest financial reports the company's total debt is NZ$0.20 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

MannKind Corp - Total debt on balance sheet (from 2006 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$84.57 M-80.38%
2023-12-31NZ$0.43 B-1.84%
2022-12-31NZ$0.43 B6.28%
2021-12-31NZ$0.41 B141.54%
2020-12-31NZ$0.17 B-5.11%
2019-12-31NZ$0.18 B17.99%
2018-12-31NZ$0.15 B-30.81%
2017-12-31NZ$0.22 B3%
2016-12-31NZ$0.21 B-31.47%
2015-12-31NZ$0.31 B8.97%
2014-12-31NZ$0.28 B-5.74%
2013-12-31NZ$0.30 B-24.46%
2012-12-31NZ$0.40 B-35.5%
2011-12-31NZ$0.62 B8.45%
2010-12-31NZ$0.57 B50.71%
2009-12-31NZ$0.38 B56.01%
2008-12-31NZ$0.24 B68.01%
2007-12-31NZ$0.14 B-7.62%
2006-12-31NZ$0.15 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Halozyme Therapeutics
HALO
NZ$2.61 B 1,159.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$27.54 B 13,172.70%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Merck
MRK
NZ$71.61 B 34,404.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$73.57 B 35,348.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$0.15 B-23.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$105.32 B 50,644.73%๐Ÿ‡บ๐Ÿ‡ธ USA